Ikarian Capital »

Proqr Thrapeutics N V shs euro shares owned by Ikarian Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $880k 484k 1.82
2024-06-30 $803k 484k 1.66
2024-03-31 $1.1M 484k 2.27
2023-12-31 $936k 473k 1.98
2023-09-30 $614k 473k 1.30
2023-06-30 $766k 473k 1.62
2023-03-31 $1.0M 473k 2.13
2022-12-31 $1.6M 423k 3.70

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Proqr Thrapeutics N V shs euro

Privium Fund Management B.V.
EcoR1 Capital
M28 Capital Management
DAFNA Capital Management
Ghost Tree Capital
Macquarie Group
Ikarian Capital
Schonfeld Strategic Advisors
Monaco Asset Management SAM
Franklin Street Advisors
Two Sigma Advisers
Deutsche Bank Aktiengesellschaft
Susquehanna International
Acadian Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro